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Self assembly of HIV-1 Gag protein 
on lipid membranes generates 
PI(4,5)P2/Cholesterol nanoclusters
Naresh Yandrapalli1, Quentin Lubart2, Hanumant S. Tanwar3, Catherine Picart2, 
Johnson Mak3, Delphine Muriaux1 & Cyril Favard1
The self-assembly of HIV-1 Gag polyprotein at the inner leaflet of the cell host plasma membrane is the 
key orchestrator of virus assembly. The binding between Gag and the plasma membrane is mediated 
by specific interaction of the Gag matrix domain and the PI(4,5)P2 lipid (PIP2). It is unknown whether 
this interaction could lead to local reorganization of the plasma membrane lipids. In this study, using 
model membranes, we examined the ability of Gag to segregate specific lipids upon self-assembly. We 
show for the first time that Gag self-assembly is responsible for the formation of PIP2 lipid nanoclusters, 
enriched in cholesterol but not in sphingomyelin. We also show that Gag mainly partition into liquid-
disordered domains of these lipid membranes. Our work strongly suggests that, instead of targeting 
pre-existing plasma membrane lipid domains, Gag is more prone to generate PIP2/Cholesterol lipid 
nanodomains at the inner leaflet of the plasma membrane during early events of virus assembly.
The retroviral Gag protein drives the assembly process of the Human Immunodeficiency Virus type 1(HIV-1) 
particles1,2. This protein is synthesized as a polyprotein Pr55 Gag, which contains three major structural domains, 
namely matrix (MA), capsid (CA) and nucleocapsid (NC), as well as two spacer peptides, sp1 and sp2 and an 
unstructured C-terminus p6 peptide. Each of these domains are known to have a specific and distinct function 
during the viral assembly process. Importantly, the N-terminal MA domain targets Gag to the plasma membrane 
and mediates membrane binding, the CA domain is responsible for Gag-Gag interaction and self-assembly and 
the NC domain recruits the viral RNA that also acts as a scaffold for viral particle assembly3. Although it has 
recently been shown that HIV assembly may be initiated in the cytosol4, it is commonly accepted that the for-
mation of large HIV-1 assembly complex mainly occurs at the plasma membrane (PM) of the virus producing 
cells. Two main features of the N-terminal MA domain of Gag govern the HIV-1 Gag inner leaflet PM binding: 
the N-terminal myristate and the highly basic region (HBR) that contains a specific binding pocket for the phos-
phatidyl inositol (4,5) bisphosphate lipid (PI(4,5)P2 or PIP2)5. PIP2 has been shown to play a major role in HIV-1 
assembly in cells since cellular depletion of PIP2 decrease the efficiency of viral particle release6. In addition, PIP2 
is also enriched in the virus envelope relative to the PM of the virus-producing cells7. This lipidomic analysis also 
shows that HIV particles are enriched in sphingolipids and cholesterol7 supporting the idea that the viral parti-
cles are released from the so called “rafts” domains. Historically, Gag has been shown to associate with detergent 
resistant membrane (DRM) by cell membrane fraction assays8,9. Nevertheless, the exact composition of these 
“rafts” or DRM is controversial10,11. Indeed, many different types of “rafts” may exist within the plasma membrane 
as long as they are enriched in cholesterol and sphingolipids12. However, Gag self-assembly occurs at the inner 
leaflet of the cellular PM where sphingolipids are poorly present. Moreover, natural PIP2, the main interacting 
partner of Gag, has a polyunsaturated fatty acyl residue at the sn-2 position of the glycerol backbone. This acyl 
chain polyunsaturation is not in favour of PIP2 partitioning into rafts13. To circumvent such a constrain, Saad et al. 
suggested a model based on NMR data using truncated acyl chains PIP25. In this model, the sn-2 acyl chain of 
the PIP2 is removed from the plane of the membrane and trapped into an hydrophobic pocket of MA. However, 
coarse grained dynamics studies14 and new NMR experiments using full length acyl chain PIP215 showed the 
opposite. Finally, recent experiments using either a multimerizable matrix domain of HIV-1 Gag16 or RSV Gag17 
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also exhibited contradictory results regarding their partitioning in lipid domains of giant unilamellar vesicles 
(GUVs).
Therefore, the ability of the Gag/PIP2 complex to partition preferentially into “raft” domains or more generally 
into PM pre-existing domains to enhance virus assembly is still a matter of controversy18. In order to elucidate 
whether Gag would bind to pre-existing “rafts” or lipid domains in the PM or generate its own lipid domains for 
assembling, we first decided to monitor its binding and partitioning to single or dual-phase model membranes 
made with simple and complex lipid compositions (see Table 1 for detailed composition of lipid mixtures). On 
GUVs, we observed that Gag was mainly partitioning into liquid-disordered (Ld) phase, i.e. more likely out of 
“rafts” microdomains in the dual-phase model membrane and that Gag was not generating micrometer range 
lipid phase separation in single phase model membranes.
We therefore monitored, at the nanoscale level, a possible PIP2, cholesterol (Chol) and sphingomyelin (SPM) 
reorganization during Gag self-assembly. Unfortunately, direct imaging of lipid nanodomains generation is not an 
easy task. Even the presence of pre-existing lipid nanodomains has indirectly been revealed by monitoring lipid 
diffusion19–23. Although accurate in detecting and measuring the size of pre-existing nanodomains, direct imag-
ing is not fast enough to follow the generation of nanodomains. Therefore, we decided to use indirect approaches 
such as fluorescence quenching24,25 or Forster Resonant Energy Transfer (FRET)26. FRET or self-quenching 
occurs when two (similar or different) fluorescent molecules are found together within a 3 to 10 nm radius.
Starting from a simple lipid mixture and using self-quenching experiments of respectively PIP2, Chol and 
SPM, we monitored the generation of Gag induced lipid nanodomains. We then performed the same type of 
experiments with dual labelling of the lipids (Chol and PIP2, or SPM and PIP2) followed up by FRET experiments 
to analyse how Gag was differently sorting these lipids during its self-assembly. We finally extended this study to 
more complex lipid compositions mimicking either lipid “rafts” or inner leaflet of the PM.
Our results show that Gag self-assembly is able to generate PIP2 nanodomains on model membranes with any 
of the composition we tested here. Importantly, these nanodomains contain Chol but not SPM.
Results
Since PIP2, Chol and SPM have been shown to be enriched in the virus envelope7, the impact of Gag self-assembly 
on their lateral distribution was tested in different types of model membranes (Fig. 1A) exhibiting different lipid 
compositions. Large unilamellar vesicles (LUVs) were firstly used in order to easily control the protein over lipid 
molecular ratio. Given that the plasma membrane of HIV producing cells (~10 μm in diameter) has reduced level 
of curvature compared to these LUVs (100 nm in diameter), we have also used supported lipid bilayers (SLBs) as 
membrane models for analyses. Gag is known to bind specifically PIP227. We then started with a simple PIP2 con-
taining lipid mixture (PC/PS/PIP2 hereafter called “basic”) in which we introduced Chol or SPM (hereafter called 
“substituted basic”). Obviously, cellular PM have more complex lipid compositions. We therefore decided to 
extend our study to compositions mimicking either the inner leaflet cellular plasma membrane28 (hereafter called 
“inner leaflet”) or the “lipid rafts” domains (i.e. two separated phases, a liquid disordered (Ld) and a liquid ordered 
(Lo) enriched in cholesterol and sphingomyelin, hereafter called “rafts-mimicking”16). Table 1 gives the exact 
compositions of the lipid mixtures used in this study. To assess a potential reorganisation of these lipids during 
Gag self-assembly, we used full-length Gag (FL-Gag) and different mutants. Theses mutants include: (1) a mutant 
of CA involved in CA-CA interaction and Gag self-assembly (WM)29 (2) Gag lacking the C-terminus NC-sp2-p6 
domains that is involved in NC-RNA association (P39). The membrane binding domain alone of Gag (MA) was 
also tested (see Fig. 1B). Finally, a cellular PM PIP2 binding protein, the PH domain of EFA6 (PH-EFA6)30 and a 
peptide, MARCKS (151–175) that is known to laterally redistribute PIP224 were used as controls.
HIV-1 Gag efficiently binds model membranes containing PIP2. The ability of the different proteins 
and peptide to bind LUVs and SLBs was analysed using membranes of “basic” composition. For this purpose, 
we monitored protein binding with two different techniques. On one hand, we performed LUV cosedimenta-
tion assays at fixed protein concentration (1 μM) and increasing PIP2 concentrations. After 15 min of incuba-
tion, LUV bound proteins were separated from unbound proteins by ultra-centrifugation. The pellet (P) and the 
Basic Substituted Basic Inner Leaflet# Rafts-mimicking#
Lipid Mol% Lipid Mol% Lipid Mol% Lipid Mol%
EggPC 68 Egg PC 66 Egg PC 17 DOPC 31
Brain PS 30 Brain PS 30 Brain PS 17 DOPS 6
Brain PI(4,5)P2 2 Brain SM 9 Brain SM 30
Cholesterol 30 Cholesterol 25
Liver PE 25 GM1 1
LUV
Brain PI(4,5)P2 0 or 1.5 Brain PI(4,5)P2 0 Brain PI(4,5)P2 5
TF-PIP2 2 or 0.5 TF-PIP2 2 TF-PIP2 2
SLB
Brain PI(4,5)P2 1 Brain SM or Chol. 1 Brain PI(4,5)P2 1 Brain PI(4,5)P2 6
TF-PIP2 1 TF-SM or TF-Chol 1 TF-PIP2 1 TF-PIP2 1
GUV
Brain PI(4,5)P2 1 Brain PI(4,5)P2 1 Brain PI(4,5)P2 6
TF-PIP2 1 TF-PIP2 1 TF-PIP2 1
Table 1.  Different lipid composition of LUV, SLB and GUV used in the single labeled lipid experiments. 
#Adapted from ref. 28. #Adapted from ref. 16.
www.nature.com/scientificreports/
3Scientific RepoRts | 6:39332 | DOI: 10.1038/srep39332
supeRNAtant (S) were deposited on a denaturating gel to quantify the amount of bound (P) and unbound (S) 
proteins (Fig. 2A). On the other hand, we used Quartz Crystal Microbalance (QCM) to monitor the association 
of proteins to SLBs containing a fixed PIP2 concentration. SLBs were formed onto the quartz crystal. Proteins were 
then injected at increasing concentrations (from 10−2 to 10 μM) and the change in the resonance frequency of the 
quartz crystal was monitored (Fig. 2B). This change in frequency is directly connected to the mass increase at the 
surface of the quartz crystal.
The ratio of membrane bound to unbound protein is linked to an apparent partition coefficients (Kp). Kp 
were determined by fitting, with eq. 1, the plots of membrane bound protein with either increasing concentra-
tions of lipids (Fig. 2C) or increasing concentration of protein (Fig. 2D). Except for MA, Kp obtained for other 
proteins were less than 1 μM. The results, summarized in Table 2, are in good agreement with the previously 
obtained Kp values for some of the different proteins used in this study. Interestingly, the Kp values of MARCKS 
and PH-EFA6 (0.7 < Kp < 0.8 μM) were found to be in the range of the one obtained for Gag (FL) and its mutants 
(0.2 < Kp < 0.8 μM). This shows that the ratio of membrane bound over total protein will be equivalent for all 
these proteins, allowing, therefore, direct comparisons of their respective role on the lateral sorting of PIP2 after 
membrane binding.
FL-Gag is mainly partitioning to Ld phases and does not induce micrometer phase separation. 
We firstly monitored the possible existence of Gag induced micrometer-range PIP2 domains by imaging 
the surface distribution of a fluorescently labelled PIP2 (namely Top-Fluor PIP2 or TF-PIP2) and a fluores-
cently labeled FL-Gag (FL-Gag Alexa 549 or A549-FL-Gag) in “basic” GUVs. As expected, both TF-PIP2 and 
A549-FL-Gag showed a uniform distribution over the surface of the GUV (Fig. 3A). The same uniform dis-
tribution was also observed with “inner leaflet” GUVs (Fig. 3A). Spatial auto-correlation of the fluorescence 
of either PIP2 or FL-Gag (Fig. 3B) both exhibited fast decorrelation showing that the fluorescent labelling of 
PIP2 is not inducing micrometer partitioning per se and that, if they exist, the PIP2 clusters are less than 200 nm 
size (i.e. below the diffraction limit). Interestingly, labelled FL-Gag was essentially restricted to Ld phases in the 
“rafts-mimicking” GUVs (Fig. 3C and D), confirming what was already observed by Keller et al.16 with a multim-
erized derivative of MA. This strongly suggested that FL-Gag preferentially binds and remains in non “rafts”/Lo  
lipid phases.
HIV-1 Gag self-assembly induces PIP2 nanoclustering. The lack of micrometer scale PIP2 induced 
domains lead us to monitor, using self-quenching experiments, a possible PIP2 lateral redistribution upon Gag 
self-assemby on LUVs or SLBs. As stated in the introduction, self-quenching occurs when two fluorescent mole-
cules are close to each other (3 < r < 10 nm). To perform these experiments, we first controlled that increasing 
concentrations of MARCKS induced an increasing quenching of the TF-PIP2 as it was reported before with 
Bodipy TMR-PIP2 (BT-PIP2)24 (See SI Fig. S1). We then monitored the change in TF-PIP2 fluorescence after addi-
tion of Gag or its mutants on “basic” LUVs in order to correctly control the protein to accessible PIP2 ratio 
Figure 1. Scheme of the different lipid membranes and proteins used in this study. (A) Representation of 
the model lipid membranes and of an elongated FL-Gag protein used in this study (see Table 1 and SI Table S1 
for all the different lipid compositions used in this study). (B) Schematic representation of the different Gag 
mutants used in this study, emphasizing the mutations and the differences in the domains present for each 
mutant.
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(P PIP/ acc2 ). We observed an increase in TF-PIP2 fluorescence (Fig. 4A) opposite to MARCKS. From Fig. 4B it was 
evidenced that addition of increasing concentrations of FL-Gag, P39 and WM induced an increasing fluorescence 
Figure 2. Binding of FL-Gag, its mutants and PH-EFA6 to “basic” lipid membranes. (A) Typical SDS-
PAGE obtained after co-sedimentation assay for FL-Gag with increasing concentrations of LUV containing 
2% mol PIP2 (P:Pellet, S:SupeRNAtant). (B) Typical change in resonance frequency observed during QCM-D 
experiments after addition of the different proteins at different concentrations on a basic composition SLB.  
(C and D) Binding isotherm curve obtained from co-sedimentation assays ((C), n = 3) and QCM-D 
experiments ((D), n = 2) for the different proteins used in this study. Experimental values were fitted using 
equation 1. Kp obtained from these binding isotherms are summarized in Table 2.
Protein
Kp(μM) Kp(μM)
Kp(μM) Lip. Comp (mol %) Ref.LUV SLB
FL 0.13 ± 0.05 0.40 ± 0.11 0.88 ± 0.20 (LUV) POPS (100) 55
P39 0.66 ± 0.44 0.47 ± 0.26
WM 0.56 ± 0.26 0.26 ± 0.13
MA
1.72 ± 1.05 2.46 ± 1 (LUV) POPS (100) 55
7.16 ± 3.33 8.2 ± 0.7(SLB) DOPC:DOPS:PI(4,5)P2(80:15:5) 39
PH-EFA6 0.88 ± 0.27 0.68 ± 0.03 0.5 (SLB)
PC:PE:PS:PI(4,5)P2 30
(34:34:30:2)
MARCKS n.d.# 0.65 ± 0.23 4.4 ± 1 (LUV)
PC:PI(4,5)P2 56
(99:1)
Table 2.  Apparent Kp of the different proteins used in this study. #Could not be determined by this method.
www.nature.com/scientificreports/
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unquenching of TF-PIP2. On the other hand, adding increasing concentrations of MA did not generate any 
change in the fluorescence of TF-PIP2. Identically, PH-EFA6, known to specifically bind PIP2 without 
Figure 3. Fluorescence distribution of TF-PIP2 and A594-FL-Gag on “Basic”, “Inner Leaflet” and “rafts-
mimicking” GUVs. (A) Left, localization of TF-PIP2 (green) and A594-FL-Gag (red) in a “Basic” composition 
GUV. Right, localization of TF-PIP2 (green) and A594-FL-Gag (red) in an “Inner Leaflet” composition GUV, 
(scale bar 5 μm). (B) Spatial autocorrelation of the fluorescence intensities of TF-PIP2 (in green) and A594-FL-
Gag(in red) for the “Basic” composition calculated using eq. 2, (mean ± s.d., n = 4). (C) Localization in “Raft” 
GUVs (F) of TF-PIP2 (green), A594-FL-Gag (red) and GM1, a raft partitioning ganglioside, labeled with alexa 
647 cholera toxin B (A647 Ctx-B)(blue), (scale bar 5 μm). (D) Partitioning in Lo and Ld phase of “raft” GUVs for 
A-594 FL, TF-PIP2 and A647-CtxB (mean ± s.d., n = 25) as determined using eq. 3.
www.nature.com/scientificreports/
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Figure 4. PIP2 nanoclustering induced by Gag self-assembly on basic composition lipid membranes.  
(A) Typical time course of TF-PIP2 fluorescence on LUVs after addition of the different proteins or peptide at a 
P/PIPacc2  = 10. (B) Relative quenching values observed for FL-Gag, its mutant, MA and PH-EFA6 on LUVs 
(mean ± s.d. values of n ≥ 3 for each P PIP/ acc2  conditions, except P39 (2 ≤ n ≤ 3)). (C) Differences in WM and  
FL-Gag self-assembly efficiency on LUV at two different P/PIPacc2  ratio. Bar graph represents the mean signal 
observed for monomers dimers and trimers & multimers obtained from independent experiments (mean ± s.d., 
n = 3). (D) Typical time course of TF-PIP2 fluorescence on SLBs after addition of 1 μM of the different proteins 
or peptide. (E) Fluorescence time course of TF-PIP2 after addition of increasing FL-Gag concentrations.  
(F) Schematic representation of the effect of an immobile fraction on the fractional recovery. Upper part, 
without Gag, fractional recovery = 1. Lower part, with Gag, self assembled Gag trapped PIP2 are still in the 
bleached area leading to a normalized fractional recovery < 1. (G) Plot box of the fractional recoveries obtained 
from FRAP measurements before and after addition of increasing concentrations of FL-Gag on SLB containing 
either DiIC18 as a lipid analogue control (left) or TF-PIP2 (right). (Boxes are 25,75% with bars max and min 
values of n ≥ 15, ***p ≤ 10−3 for Student t-test at 0.01 confidence level).
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7Scientific RepoRts | 6:39332 | DOI: 10.1038/srep39332
reorganizing its lateral distribution, did not produce any effect either (Fig. 4A and B). A major difference between 
the Gag matured protein MA and the precursor proteins (FL-Gag, P39 and WM) is their capacity to form large 
oligomer complexes via the CA-CA interactions31, although WM is less efficient (two orders of magnitudes in 
solution) in supporting the formation of large Gag lattice, due to its inability to dimerize with nearby CA hex-
amer29. Interestingly, this fluorescence unquenching was always less efficient in the case of WM compared to 
FL-Gag (from 3 to 5 times), indicating that this fluorescence variation depended on the capacity of Gag to mul-
timerize. To support this hypothesis, FL-Gag and WM were incubated with “basic” LUVs for 15 minutes followed 
by ultracentrifugation. The self-assembly states of WM and FL-Gag bound to LUVs were analysed by performing 
a non denaturating gel electrophoresis to preserve existing multimers, followed by immunoblot. Figure 4C 
showed that, in the two P PIP/ acc2  ratio tested, WM was at least two times less efficient than FL-Gag in multimeriz-
ing on membranes (Fig. 4B). This ratio was in the range of the relative efficiency of TF-PIP2 unquenching 
observed between FL-Gag and WM. This confirmed the role of Gag self-assembly in the observed TF-PIP2 fluo-
rescence changes. Although LUVs provide a simple, reliable and easy to control (in terms of protein to lipid 
ratios) model membranes, Gag self-assembly usually occurs on membranes with higher radius of curvature. 
Therefore, time course fluorescence self-quenching of TF-PIP2 were also conducted on “basic” SLBs. For FL-Gag 
and P39 the TF-PIP2 fluorescence intensity of SLBs decreased (Fig. 4D). This change in intensity was opposite to 
the one observed with LUVs (Fig. 4A) while still being a function of the protein concentration (Fig. 4E for 
FL-Gag). As it was the case for LUVs, the TF-PIP2 quenching induced by addition of the WM mutant was less 
efficient than in the case of FL-Gag. PH-EFA6 and MA did not induced changes in TF-PIP2 fluorescence (Fig. 4D). 
Interestingly, Fig. 4D shows that MARCKS addition induced the same TF-PIP2 quenching on SLBs and LUVs 
(see Fig. 4A). This suggest that model membrane curvature (curved LUV vs flat SLBs) is responsible for the oppo-
site quenching observed with Gag and its mutants on SLBs and LUVs (see SI Fig. S2 for detailed explanation). 
Altogether these results show that the self-assembly of HIV-1 Gag is generating TF-PIP2 clusters.
Diffusion of Gag is expected to slow down upon self-assembly. Hendrix et al.4 already observed that Gag 
multimers exhibited a diffusion coefficient(D) of 0.01 μm2.s−1 at maximum. If PIP2s are tightly trapped in Gag 
multimers they will diffuse with similar coefficient as that of these Gag multimers. Consequently, the fluorescence 
of a 1 μm radius area containing these multimers and labelled PIP2, should not totally return to its initial level 15s 
after photobleaching (Fig. 4F). This will lead the normalized fluorescence recovery value (NFR, defined in eq. 4, 
0 < NFR < 1) to be less than 1. We monitored this change in normalized fluorescence recovery in the absence or 
presence of FL-Gag. For that purpose, in the time course of quenching experiments, we performed Fluorescence 
Recovery After Photobleaching (FRAP) experiments before (start of the quenching experiment) and after (end 
of the quenching experiment) addition of FL-Gag on SLBs. In the absence of FL-Gag, normalized fluorescence 
recovered to 1, as expected for freely diffusing lipids (Fig. 4G, right). On the opposite, addition of increasing 
FL-Gag concentrations induced a decrease in PIP2 normalized fluorescence recovery as well as an increase in flu-
orescence quenching (previously shown in Fig. 4E). We controlled that the decrease in normalized fluorescence 
recovery was specific of PIP2. Indeed, we did not observe any change in the normalized fluorescence recovery of a 
lipid analogue fluorescent dye (diIC18, see materials in SI) in the presence or in the absence of Gag (Fig. 4G, left).
Our data clearly show that HIV-1 Gag is sorting PIP2 in the lipid membrane and that Gag self-assembly gen-
erates PIP2 nanoclusters in model membranes.
Cholesterol but not sphingomyelin is sensitive to HIV-1 Gag self-assembly. Since Chol and SPM 
are supposed to be the main lipid components of “raft” domains, their enrichment into the Gag self-assembly 
induced PIP2 nanoclusters was also assessed. 2% mol of egg phosphatidyl choline (EPC) present in our “basic” 
lipid composition, were substituted either by SPM or by Chol with half of them being labelled with TF derivatives 
(see Table 1 for detailed composition). This substitution allowed the net surface charge and the PIP2 content to be 
maintained, limiting any drastic change in the partitioning constant Kp. Time course fluorescence change of either 
TF-SPM or TF-Chol were then monitored after FL-Gag addition. Figure 5A shows that FL-Gag addition had no 
effect on TF-SPM fluorescence whereas Fig. 5B shows that increasing concentrations of FL-Gag induced increas-
ing quenching of TF-Chol, as it was the case for TF-PIP2 (Fig. 4E). This shows that FL-Gag self- assembly is able to 
generate Chol-enriched lipid nanodomains whereas it is not changing the SPM lateral distribution. Co-clustering 
of these molecules was also assessed by simultaneously monitoring the change in fluorescence upon addition of 
FL-Gag with either TF-SPM and BT-PIP2 (Fig. 5C) or TF-Chol and BT-PIP2 (Fig. 5D) labelled SLBs (see SI Table 1 
for exact dual labelled lipid membranes compositions). TF-Chol and BT-PIP2 exhibited simultaneous quenching 
after addition of various concentration of FL-Gag, suggesting that TF-Chol and BT-PIP2 are co-clustered in Gag 
self-assembly induced nanodomains. In contrast, while BT-PIP2 was quenched as previously, TF-SPM exhibited 
a surprising apparent fluorescence unquenching after Gag addition. This was an unexpected result regarding 
the TF-SPM quenching induced by FL-Gag self-assembly in the presence of unlabelled PIP2 (Fig. 5A). Since this 
apparent unquenching of TF-SPM upon addition of FL-Gag only occurred when BT-PIP2 was present (see Fig. 5A 
vs Fig. 5C), we checked if TF-SPM (as a donor) and BT-PIP2 (as an acceptor) were able to exhibit FRET. Donor 
FRET efficiency has been shown to be a function of acceptor concentration in a lipid bilayer32. This means that the 
FRET efficiency will decrease if acceptor (BT-PIP2) local concentration decreases and that, as a consequence, the 
fluorescence of the donor (TF-SPM) will increase. We tested this by performing acceptor photobleaching experi-
ments in order to decrease the acceptor concentration, locally and reversibly. We observed that, in the area where 
the acceptor (BT-PIP2) was bleached, the fluorescence of the donor (TF-SPM) increased. This effect was abolished 
when concentrations were re-equilibrated by diffusion (see SI Fig. 3). In our TF-SPM/BT-PIP2 co-clustering assay, 
we observed a decrease in BT-PIP2 due to Gag self-assembly induced quenching and concomitantly, a non revers-
ible TF-SPM fluorescence increase due to loss in FRET efficiency induced by decreasing concentration of acceptor 
(TF-PIP2). This can only be explained by considering that Gag self-assembly clusters BT-PIP2 without TF-SPM.
www.nature.com/scientificreports/
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Altogether, these results show that HIV-1 Gag self-assembly is generating common PIP2 and cholesterol nan-
odomains while excluding sphingomyelin.
HIV-1 Gag is driving PIP2 and cholesterol nanoclustering independently of surrounding 
lipids. Because cellular PMs are complex lipid mixtures, we examined a possible role of this complexity on the 
lateral sorting of PIP2, Chol and SPM during HIV-1 Gag self-assembly. For that purpose, we used the two other 
different lipid mixture mimicking either the inner leaflet of cells PM (“inner-leaflet”) or the “rafts” lipid mixture 
(“raft-mimicking”) (see Table 1 and SI Table 1 for detailed lipid composition). We first compared the effect of 
FL-Gag self-assembly on PIP2 clustering for these three lipid compositions. No characteristic change in TF-PIP2 
fluorescence unquenching with increasing concentrations of FL-Gag (LUVs, Fig. 6A) or fluorescence quenching 
(SLBs, Fig. 6B) could be clearly detected amongst the three different lipid compositions. We then tested again 
Chol and SPM ability to partition into these FL-Gag induced PIP2 nanoclusters in the complex lipid mixtures. 
Figure 5. Gag self-assembly is sorting cholesterol but not sphingomyelin. (A and B) Typical fluorescence 
time course after addition of increasing FL-Gag concentrations on subsituted basic SLBs labeled with TF-
SPM (A) or TF-Chol (B). (C and D) Simultaneous fluorescence time course after addition of increasing 
concentrations of FL-Gag on substituted basic SLBs labelled with TF-SPM (in green) and BT-PIP2 (in red) (C) 
or TF-Chol (in green) and BT-PIP2 (in red) (D).
www.nature.com/scientificreports/
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Figure 6. Gag PIP2 and Chol nanoclustering in complex membrane models. (A and B) TF-PIP2 fluorescence 
changes in lipid membranes of different composition (basic, Inner Leaflet, Raft) using LUVs (A) relative 
quenching of at different P/PIPacc2  ratio. mean ± s.d., n ≥ 3) or SLBs (B) typical time course of TF-PIP2 
fluorescence after addition of 1 μM FL-Gag.) (C) Simultaneous fluorescence time course obtained on “inner 
leaflet” SLBs for BT-PIP2 (in red) and in green TF-SPM (left panel) or TF-Chol (right panel). (D) Simultaneous 
fluorescence time course obtained on “raft” SLBs for BT-PIP2 (in red) and in green TF-SPM (left panel) or TF-
Chol (right panel).
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Figure 6C (TF-SPM/BT-PIP2) and 6D (TF-Chol/BT-PIP2) exhibited the same tendency for the fluorescence time 
courses of labelled lipid upon FL-Gag addition on SLBs, independently of the lipid composition.
These results show that, as in the “basic” composition, in complex lipid mixtures the PIP2 nanoclusters 
induced by Gag self assembly are enriched in Chol but not in SPM. This clearly suggest that Gag is sorting these 
lipids during self-assembly independently of the surrounding lipids chemical nature and acts as the driving force 
for lipid reorganization during HIV-1 assembly.
Discussion
Although the MA domain is primary responsible for HIV-1 Gag binding to the PM, the ten times higher apparent 
affinity for membrane models observed here in the case of FL-Gag, P39 and WM confirms that the NC domains 
and CA-CA self-assembly of Gag are involved in membrane binding efficiency. Indeed, the NC domain of Gag 
alone has recently been described to bind to PIP2 containing lipid membranes with an apparent Kp as high as 
7 μM33. It has also already been shown that the driving force for membrane association stems largely from ionic 
interactions between multimerized Gag and negatively charged phospholipids34.
Using micrometer scale phase separated GUVs, we have observed that Gag was mainly partitioning in Ld 
phases, i.e., more likely outside of lipid “rafts” (namely Chol and SPM enriched) domains. The lack of myristate in 
the different Gag variants tested here could explain the Gag Ld phase localization35. Nevertheless, our results are 
consistent with the Ld phase GUV localization of multimerizable myr(+ )MA protein observed by Keller et al.16. 
However, it is known that cholesterol is crucial for virus infectivity36,37 and that Gag can sense cholesterol38,39. 
It was recently described that PIP2 could form clusters in the presence of cholesterol alone40. Here we show that 
PIP2 and cholesterol are laterally redistributed upon Gag self-assembly on membranes and participate to the 
formation of cholesterol/PIP2/Gag enriched nanodomains. Importantly, we also show that sphingomyelin is not 
sorted during HIV-1 Gag self-assembly and is excluded from the Gag/PIP2/Chol nanoclusters. Taken together, 
these results suggest that binding and self-assembly of Gag protein does not occur in pre-existing lipid domains 
(such as “rafts”) but that this self-assembly is more likely to induce lipid nanodomains. 
It is known that plasma membrane lipid organization is not only driven by lipid-lipid interactions. For exam-
ple, cytoplasmic proteins such as ezrin41,42, syntaxin-143 have also been described to induce or interact with PIP2 
nanoclusters. As a general mechanism, proteins with basic interfaces can recruit acidic lipids that, in turn, can 
facilitate recruitment and clustering of these proteins into nanodomains44,45. A similar cooperative mechanism 
could also happen when HIV-1 Gag binds to PIP2 during viral assembly at the plasma membrane. Interestingly, 
mesoscale organized structures such as cortical actin network has also been shown to play an important role in 
the lateral organization of not only transmembrane proteins, but inner leaflet plasma membrane lipids such as 
PIP246 and more interestingly outer leaflet components such as GPi-anchored proteins47. Moreover, this cortical 
actin network has also been shown to play a role in HIV-1 Gag assembly at the PM of Jurkat T-cells48.
Since HIV-1 Gag has been often found in DRMs8, pre-existing outer leaflet “rafts” could be trapped by these 
nascent PI(4,5)P2-Gag nanodomains through transbilayer coupling - as we already proposed18 or as it has been 
recently shown for lipid domains49 and for outer leaflet GPi anchored proteins50. Moreover, a recent study of the 
SPM dynamic in the cellular PM revealed that instead of clearly partitioning into nanodomains, SPM was mainly 
transiently trapped51. In the case of the ganglioside GM1, another lipid described as partitioning into Lo phases, 
its transient trapping was shown to depend on molecular pinning and interleaflet coupling between lipid tail 
domains52. This suggest that Gag could not only generates his own lipid nano-domains at the inner leaflet of the 
cellular PM but also induce the formation of domains in the outer leaflet of the cellular PM by transiently trapping 
SPM or other components.
Finally, we also observed that the matrix domain of Gag is not able to induce this PIP2 clustering, suggesting 
that, after maturation and particle release, the inner leaflet lipids of the virus envelope might be free to diffuse 
again.
Conclusion
We have shown using simple and cell mimicking lipid composition model membranes that Gag self-assembly 
is inducing nano-clusters enriched in PIP2 and cholesterol, instead of partitioning to pre-existing ones. This 
lipid nano-clustering does not require sphingomyelin and mainly occurs out of the Lo phases in GUVs. Further, 
the different lipid composition tested here does not strikingly affect the capacity of Gag to induce these lipid 
nano-clusters suggesting that Gag is able to sort its own lipids independently of the surrounding lipids.
Methods
All experiments were performed at room temperature (RT). Experimental buffer was Hepes 10 mM, pH = 7.4, 
KCl 150 mM, EDTA 2 mM except for QCM-D binding experiments. All images were acquired with a Zeiss LSM 
780 microscope (Carl Zeiss, Inc.) using a 63x NA 1.4 oil objective and quantified using Image J software (NIH, 
MD, USA). Detailed materials, methods for model membranes (LUV, GUV, SLB) preparation and for protein 
purification are in SI.
Binding experiments. Kp were determined on basic lipid composition (EPC 68%, BPS 30% & PI(4,5)P2 2% 
for LUVs or POPC 68%, POPS 30% & PI(4,5)P2 2% for SLBs). Methods used were either cosedimentation assays 
for LUVs or QCM-D experiments on SLBs. Co-sedimentation assays were made at 1 μM protein concentration 
with varying concentrations of total accessible lipids from 0.07 to 2250 μM in 100 μl of the same buffer that the 
one used in quenching experiments, according to the protocol in ref. 53. After 15 min of incubation at room tem-
perature, samples were centrifuged at 220,000 g for 1 h at 4 °C using a Beckman Coulter’s TLA 100 rotor. The top 
80 μl was considered as supeRNAtant (S) and the remaining 20 μl diluted with 60 μl of working buffer as pellet (P). 
Pellet and supeRNAtant were analyzed on a 10% SDS-PAGE and stained using coomassie blue. Quantifications 
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were made using Image J software (National Institutes of Health, MD, USA). SLBs were prepared with 0.1 mg.mL−1 
liposomes flowing at 10 μL.min−1 for 10–20 min on a UV-treated SiO2 surface of Q-sensor fixed in a Q-Sense 
Flow module, QFM 401 Biolin Scientific, Sweden). Stable SLBs were rinsed with citrate buffer (NaCitrate 10 mM, 
100 mM NaCl, and 0.5 mM EGTA, pH 4.6) and then with injection buffer (5 mM Tris & 100 mM NaCl pH 7.4). 
At equilibrium, 200 μL of increasing protein concentration was successively injected into the flow chamber fol-
lowed by rinsing steps in between. The same was repeated with increasing protein concentrations until saturation. 
Sensorgrams were normalized to third harmonic in the case of varying harmonic curves. Δ F (plateau values) 
were used to measure the lipid SLB surface fraction of protein bound. The fraction of protein bound is related 
to an apparent association constant K (i.e, the reciprocal of the apparent partitioning constant, Kp) following the 
equation:
=
+
PL
PL
K L
K L
[ ]
[ ]
[ ]
1 [ ] (1)max
acc
acc
where the percentage of protein bound is [PL] = IPellet/(IP + IS) in the case of the co-sedimentation experiments 
(IP & IS experimental intensities of pellet and supeRNAtant and IPellet = IP − 0.2.IS, for dilution compensation). In 
the case of QCM-d experiments, apparent Kp values were obtained using Eq. 1 formulated as a function of [P] 
instead of [L].
Image analysis of GUVs. GUVs were deposited on coverslips coated with casein (2 mg.mL−1) fitted in an 
Attofluor cell chamber (Thermo Fisher Scientific, Inc.). Labeled FL-Gag was added to the buffer. Spectral images 
were acquired at constant excitation intensity at 488 nm, 561 nm and 633 nm using an emission spectral range 
between 499 and 690 nm with a 8 nm resolution. Linear unmixing of these images was done to avoid potential 
bleed-through due to fluorophore emission overlapping. To establish the spatial auto-correlation of the fluores-
cence intensity of TF-PIP2 or A594-FL-Gag on basic composition GUVs, the change in intensity was plotted 
along the GUV using the following integration:
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θ θ
θ θ θ
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Intensity was plotted with r. sin θ as the length unit. The obtained curves were autocorrelated using either the 
autocorr or the xcorr function of Matlab R2015 (Mathworks®).
Intensity partition of each label in the case of raft GUVs was determined using the following equations:
∑ ∑θ θ θ θ= ∆ ∆ = −
θ θ
θ θ
θ
θ pi
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=
=
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θi and θo were determined with the help of Alexa647-CtxB intensity circular profile.
Fluorescence quenching measurements. For LUV experiments, fluorescence was monitored using 
a spectrometer (Photon Technologies InteRNAtional, Inc.) with λexc = 485 ± 2 nm and λem = 520 ± 10 nm. 
Excitation lamp intensity was calibrated using the Raman spectrum of pure water and its fluctuations corrected 
every second. For every interaction assay on LUVs, the obtained intensity curve was corrected for both bleaching 
and dilution effect and then normalized to the mean intensity before injection. In the case of SLBs, fluorescence 
was monitored by acquiring images using the Zeiss definite focus system to avoid any z-drift with a 2-photons 
excitation (930 nm) every 5 s (in order to strongly reduce photobleaching). TF-lipids fluorescence was acquired 
at 520 ± 30 nm and BT-PIP2 at 600 ± 40. Mean intensity of each image was normalized to the intensity before 
injection.
Self-assembly assay on LUVs. 100 μL of the basic LUVs was incubated at room temperature for 15 min 
with either 0.9 μM or 4.5 μM of FL-Gag or WM. After centrifugation at 10,000 g for 5 min at 4 C, 20 μL of the 
supeRNAtant was loaded on a 10% native-PAGE and proceed for immunoblot as in ref. 53. FL-Gag and WM were 
detected by a primary anti-capsid antibody (HIV-1 p24 NIH AIDS Reagents) followed by secondary antibody 
goat anti-mouse HRP conjugated. Membrane was revealed by Femto substrate (Thermo-scientific) and imaged 
by a G:Box (Syngene).
Fluorescence Recovery After Photobleaching. The image sequence was acquired at 20 Hz using the 
488 nm line of an Ar+ laser at a very low power to avoid photobleaching. After 2.5 s, 3 regions of interests (ROI), 
of 1 μm radius each, were rapidly photobleached (t < 60 ms) at maximal laser power. Fluorescence recovery was 
monitored for 15 s. The recovery curves were obtained as in ref. 54. In order to correctly estimate F0 (the fluores-
cence intensity immediately after the end of the bleach) and F15s, the curves were fitted as in ref. 54. The normal-
ized fractional recovery (NFR), is defined as:
=
−
−
NFR F F
F1 (4)
s15 0
0
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